Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clinical efficacy of tetrathiomolybdate in advanced kidney cancer

July 11, 2003

FibroGen awarded grant to develop cancer therapies

July 11, 2003

Preliminary findings reveal troponin I suppresses genes associated with angiogenesis

July 11, 2003

Evidence of antitumor efficacy found for PDX in NSCLC

July 11, 2003

IDM exercises option to license cancer epitopes from Epimmune

July 11, 2003

Recent Merck patents cover pyrimidinone KSP inhibitors

July 10, 2003

Trichostatin A potentiates the proapoptotic effects of biomodulators on hepatocellular carcinoma

July 10, 2003

Transient antitumor effects of tipifarnib in hematological malignancies

July 10, 2003

First preclinical data supporting AP-23464 as an alternative to Gleevec

July 9, 2003

PI-88 achieves primary efficacy endpoint in multiple myeloma trial

July 9, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...